slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 26,911-26,940
Pages 1,935
Rows per page 30
Slide function
26,911-26,940 of 58,039
27
The slide presents two distinct clinical data sets: a summary table for the BAYOU trial and a spider plot for the U105 trial.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
Includes a Kaplan-Meier curve for rPFS and a forest plot for HR by HRRm subgroup.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
Data presented as stacked bar charts showing CR, PR, SD, and PD components.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
The chart shows overlapping confidence intervals, supporting the conclusion of comparability.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
07
The slide presents two side-by-side tables comparing FY 2021 and Q4 2021 performance metrics.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
12
Includes footnotes regarding CER (constant exchange rates) and expense definitions.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
13
Includes footnotes regarding CER (constant exchange rates), R&D, SG&A, and percentage points.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
14
Includes historical performance data from 2018-2021 and 2022 guidance ranges.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The bridge chart includes a significant acquisition-related debt increase.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
17
The slide uses stacked bar charts to visualize revenue growth by region (US, Europe, ERoW, EM) for two key products.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
18
Includes a stacked bar chart for product sales, a list of regional growth drivers, and a stacked bar chart for collaboration revenue.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
Includes product imagery and detailed footnotes for medical abbreviations.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
22
Includes a stacked bar chart for Farxiga revenue and a line chart for Lokelma market share.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
23
Slide provides a breakdown of revenue, market share, and launch status for three specific pharmaceutical products.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
25
The chart shows a stacked bar breakdown of revenue by region (China vs Ex-China) and COVID-19 vaccine sales over 9 quarters.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
28
Slide 28 of a presentation, likely from AstraZeneca's financial reporting.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
37
The slide is split into two distinct tables: Oncology (left) and BioPharmaceuticals: CVRM (right).AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
Includes both annual (fiscal year ending Sept 30) and quarterly (three months ending Dec 31) data. RONTA stands for Return on Net Tangible Assets.Azek | Investor Presentation Deck | 38 slides · The AZEK Company
Pitch deck Investor relations Beat · Financials1 hit
36
Contains detailed footnotes explaining adjustments for asset impairment, business transformation, and other non-recurring costs.Azek | Investor Presentation Deck | 38 slides · The AZEK Company
Pitch deck Investor relations 1 hit
09
The table highlights that actual performance exceeded both original and updated guidance for both reported and pro forma revenue.Azerion | Results Presentation Deck | 20 slides · Azerion
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
12
Includes margin percentages for each period below the bar charts.Azerion | Results Presentation Deck | 20 slides · Azerion
Conference presentation Investor relations Beat · Financials1 hit
13
Waterfall charts showing adjustments for Capital Markets Expenses, Acquisitions/Disposals, and Other Non-Recurring items.Azerion | Results Presentation Deck | 20 slides · Azerion
Conference presentation Investor relations Beat · Financials1 hit
14
Includes margin percentages for each period.Azerion | Results Presentation Deck | 20 slides · Azerion
Conference presentation Investor relations Beat · Financials1 hit
15
Includes both reported and adjusted EBITDA figures with corresponding margins.Azerion | Results Presentation Deck | 20 slides · Azerion
Conference presentation Investor relations 1 hit
10
The slide uses a consistent 2x2 grid layout to present key financial performance indicators.Barclays | Credit Presentation Deck | 73 slides · Barclays
Conference presentation Investor relations Beat · Solution & ApproachLoop · Logic Chain1 hit
17
The slide uses a stacked bar chart to show income composition and a list format to explain the variance for each business unit.Barclays | Credit Presentation Deck | 73 slides · Barclays
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
19
The waterfall chart illustrates the components of the cost increase: base costs, performance costs, and structural cost actions.Barclays | Credit Presentation Deck | 73 slides · Barclays
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
20
The slide uses a stacked bar chart to show the composition of FY21 costs compared to previous years.Barclays | Credit Presentation Deck | 73 slides · Barclays
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
21
The chart uses a bridge-like structure to explain the transition from FY21 actuals to FY22 outlook.Barclays | Credit Presentation Deck | 73 slides · Barclays
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit